In order to achieve accurate quantitation of drugs and metabolites (analytes) in complex matrices, 2H-(and less commonly 130) labeled analogues of the analytes are now routinely adapted as the internal standards (IS) using linear calibration models to fit data generated by selected ion monitoring gas chromatography-mass spectrometry (GC-MS) protocols. In this study, the effects of crosscontribution (contribution of the IS to the intensity of the ion designated for the analyte and vice versa) on the linearity of the calibration data are examined. Nonlinear approaches that may address this problem are also studied. Two ion pairs (one with least and one with significant cross-contribution) from each of the following analyte/IS pairs are used as the exemplar systems for this study: butalbitalp3C4-butalbital, butalbital/2Hs-butalbital, secobarbitalP3C4-secobarbital, and secobarbital/2Hs-secobarbital. Analyte/IS ion intensity ratios of a series of standard solutions are correlated with the analyte/IS concentration ratios using onepoint, multiple-point (unweighted and weighted) linear, and hyperbolic functions. The one-point calibration approach produces excellent calibration results in treating data derived from ion pairs with no significant cross contribution. In cases where significant cross-contribution exists, results derived from the one-point approach show, as expected, significant deviations at both ends of the concentration range. With the cross-contribution phenomenon accounted for, the hyperbolic calibration model is clearly more effective in fitting calibration data at both the lower and higher analyte concentration ends, thus significantly lowering the detection limit and extending the calibration range to a higher level. However, the calibration range cannot be extended indefinitely. At the low concentration end, noise-to-signal ratio and the cross-contribution of the IS to the intensity of the ion designated for the analyte, however insignificant, will incrementally reduce the quality of the observed ion intensity and intensity ratio data. At the high concentration end, detection saturation and the cross-contribution of the analyte to the intensity
Introduction
Accurate quantitation of drugs and their metabolites (drugs/metabolites, analyte) in biological specimens is an essential function of modern forensic and toxicological laboratories. This practice is in response to government workplace drug-testing regulatory programs' emphasis on monitoring quantitative data (1) and advances and trends in detecting drugs/metabolites in biological specimens at a very low concentration level and interpretation of quantitative data with small interspecimen concentration differences (2) .
An internal standard (IS) method using 2H-analogues, and recently z3C-analogues (3), of the analytes in conjunction with selected ion monitoring (SIM) gas chromatography-mass spectrometry (GC-MS) procedures is currently the state-of-theart approach for this routine analytical need. Analogues of drugs/metabolites that are labeled with three or more 2H-atoms (or less commonly, 13C-atoms) at appropriate positions (labeled analogue) are currently considered the most effective and are therefore the most commonly used ISs (4) . This approach is effective only if there is an adequate number of sufficiently high-mass ions (typically three for a drug/metabolite and two for its labeled analogue) that can be attributed to the analyte and the IS, respectively, with no (or sufficiently low) contribution to the intensities of ions designated for the counter-component of the analyte/IS pair--a phenomenon hereby referred to as "cross-contribution" (5) . Others have also reported effects of this phenomenon on quantitative determinations (6, 7) .
For assay calibration, the analytical science community favors a linear model in relating the analytical response to the analyte's concentration. The U.S. Food and Drug Administration's current thinking on the validation of analytical procedures requires the evaluation of a linear relationship across the range of the analytical procedure. For analytical procedures in which linearity cannot be readily established, "the analytical response should be described by an appropriate function of the concentration (amount) of an analyte in a sample." (8) . However, a very recent report (9) synthesized following the workshop on "Bioanalytical Methods Validation--A Revisit with a Decade of Progress", sponsored by the American Association of Pharmaceutical Scientists and the U.S. Food and Drug Administration, recommended the use of "[standard] curve fitting...by applying the simplest algorithm (model) which best describes the concentration-response relationship using appropriate and statistical tests for 'goodness of fit' requirement." This report further emphasized the use of "the lower limit of quantitation" (LLOQ) and "the upper limit of quantitation" (ULOQ).
In theory, calibration data derived from the use of a labeled analogue as the IS, as routinely practiced in forensic and tox-icological laboratories, are rarely linear. This is caused by the cross-contribution phenomenon and the integration of chromatogram peaks (for the analyte and the IS) that are not sufficiently resolved (10) .
We have been keenly interested in various aspects of quantitative analysis and studied issues concerning the effects of isotopic impurity of labeled analogues, when used as ISs, on quantitation (11); the determination of the cross-contribution phenomenon (12) ; and the use of different derivatization alternatives to generate ions with the least cross-contribution (13) . This study will (1) examine the effects of cross-contribution on the linearity of the calibration data and (2) explore nonlinear approaches that can be used to address this problem.
Materials and Methods

Standards and reagents
Butalbital and secobarbital (analytes) in 1-mg/mL methanol solution (99% purity) and 2Hs-butalbital and ZHs-secobarbital (labeled analogues used as ISs) in 0.1-m~mL methanol solution (99% purity) were purchased from Radian (Austin, TX). 13C4-Butalbital and 13C4-secobarbital (labeled analogues used as ISs) in 1-mg/mL methanol solution (99% purity) were provided by Isotec (Miamisburg, OH Table VII.) O', r .< 1600, 2000, 2500, 3200, 4000, 5000 ng/mL. All of the standard solutions in one series included 200 ng/mL 2Hs-butalbital serving as the IS. The same concentration of 13C4-butalbital was included in each of the second series of standard solutions. Similarly, two series of standard solutions containing the following concentrations of secobarbital were prepared from a single secobarbital stock (10 pg/mL): 25, 50, 100, 200, 400, 800, 1200, 1600, 1800, 2400, 3600, 4800 ng/mL. 2Hs-Secobarbital and 13C4-secobarbital (200 ng/mL) were used as the ISs in these two series of standard solutions.
The same stocks were used to prepare all standard solutions in each set. This practice allows ruling out potential slight variation in the exact concentration of the stocks from different preparations as the cause of any deviation from linearity, if observed.
Solid-phase extraction and derivatization
Each sample includes 2 mL of the standard solution (of various concentrations) and 40 pL of 10 pg/mL IS (concentration of the IS: 200 ng/mL). Procedures provided by the Bond Elute Certify manufacturer (14) were followed. Briefly, 0.8 mL of 0.1M phosphate buffer (pH 6.0) was added to each sample (range of pH in these samples: 5.8-6.3). The specimen was applied to a conditioned column, rinsed, and then eluted with 4 mL hexane/ethyl acetate into a 5-mL disposable glass centrifuge tube. The extract was dried, then methylated and cleaned following the exact procedures described in our earlier report (5) . The final product was dried and reconstituted with 20 pL (or other specified volumes) ethyl acetate prior to GC-MS measurement. 
GC-MS analysis
With some minor changes in GC conditions, the same instrumentation and procedures (HP 5890 GC interfaced to an HP 5970 mass selective detector, MSD) used in our earlier study (5) were adapted. GC conditions adapted for butalbital study were as follows: initial temperature of 80~ was programmed to 170~ at 18~ then to 260~ at 30~ and held for 3 rain. The corresponding GC conditions adapted for secobarbital study were the initial temperature of 100~ was programmed to 150~ at 10~
then 
Regression analysis
Linear regression analyses (unweighted and weighted) were Journal of Analytical Toxicology, Vol. 25, April 2001 performed using SPSS for Windows (Release 10.05, SPSS, Chicago, IL) and a Gateway P5-120 computer (Gateway 2000
Results and Discussion
Structures and full-scan mass spectra of the three isotopic analogues (analyte and 2H-and 13C-labeled analogues) of butalbital and secobarbital are shown in Figures 1 and 2 . Fullscan MS data were used to preliminarily select the following analyte/IS ion pairs that were apparently free of (or with min- 
Cross-contribution data
In an earlier study (5), Cross-contribution data were determined by SIM procedures measuring specific ion intensity (peak areas) data derived from the same quantities of the analyte and the labeled analogue in two separate analyses. Refined procedures have since been developed and evaluated (12) . Most accurate cross-contribution data of the selected ion pairs are summarized in Tables I and II . Among all data shown in Tables I and II, (Table II) . These ion pairs were selected to demonstrate the best quantitation scenarios for the systems included in this study.
An additional ion pair with considerable cross-contribution from each analyte/IS pair was also selected for this study to demonstrate the effect of cross-contributions on assay calibration. These ion pairs are butalbital/]3C4-butalbital, m/z 138/141; butalbita~Hs-butalbital, 138/143 (Table I) ; secobarbitai/13C4-secobarbital, m/z 181/185; and secobarbital/ZHs-secobarbital, 111/116 (Table II) .
Cross-contribution from extrinsic and intrinsic sources.
Contribution to the intensity of a specific ion designated for the analyte by the labeled analogue (the IS) can originate from (1) isotopic impurity (presence of the analyte in the IS) (11) or (2) the intrinsic fragmentation mechanism of the compound. For a 2H-labeled analogue, contribution derived from the extrinsic factor (presence of the analyte in the 2H-labeled IS) is characterized by the presence of two ion peaks with slightly different retention times, that is, when the chromatographic column is operated under a sufficiently low temperature (5). Because 13C-labeled analogues have practically the same retention time as their parent compounds, this approach cannot characterize the isotopic impurity, if present, in 13C-labeled ISs. An alternate approach, based on the linearity of the ion-pair intensity ratio data, can be used to differentiate cross-contribution derived from intrinsic and extrinsic sources. For example, the linear nature of m/z 196/200 intensity ratio as a function of butalbital/13C4-butalbital concentration ratio ( Figure 3A) indicates absence of noticeable cross-contribution; thus, isotopic impurity. On the other hand, the obviously non-linear nature of the plot for m/z 138/141 ( Figure 3B ) generated by the same analyte/IS system can only be attributed to cross-contribution derived from the intrinsic fragmentation mechanism.
Similar patterns are observed for the two ion pairs selected from the butalbita~Hs-butalbital (Figures 3C and 3D ) and the secobarbitalP3C4-secobarbital ( Figures 4A and 4B) systems. The non-linear nature of both plots for the secobarbita~Hs-secobarbital system ( Figures 4C and 4D ) proscribes identifying whether the observed cross-contribution is caused by extrinsic isotopic impurity or intrinsic ion fragmentation.
Cross-contribution as the cause of deviation from linearity. The nonlinear nature of the plots ( Figures 3B, 3D , 4B-D), caused by ion cross-contribution phenomenon, renders the application of a linear model through the entire concentration range ineffective. Because ion pairs with no noticeable cross-contributions are not always available in all analyte/IS systems of interest, it is important to examine whether a nonlinear model can be effectively used for assay calibration purpose. It is also interesting to compare the effectiveness of non-linear and linear models when applied to data sets that are generated by ion pairs with no significant cross-contribution.
Regression models
Selected analyte/IS ion-pair intensity ratios observed from the butalbital/13C4-butalbital, butalbital/2Hs-butalbital, secobarbital/13C4-secobarbital, and secobarbital/2Hs-secobarbital systems are shown in the second columns in Tables III-VI. The third columns of these tables are observed concentrations and their deviations (in parentheses) from respective theoretical values using the 200-ng/mL standard in each system as the one-point calibrator. Shown in column 4 in these tables are the corresponding data derived from linear regression (weighted) using the same set of ion-intensity ratio data shown in column 2. Corresponding results derived from the hyperbolic model are shown in the last columns. Regression equations and correlation coefficients derived from the linear (weighted) and the hyperbolic models are summarized in Table VII .
One-point versus linear calibration. One-point calibration is a linear model in which the calibration line is defined by one data point (the calibrator) and the point of origin. It is interesting to note that this approach produces excellent calibration results (column 3 in Tables III-VI) Table V ). These data are superior to those generated by multipoint linear (weighted) models at the lower concentration end where the analyte concentration is lower than the internal standard.
In cases where significant cross-contribution exists, results derived from the one-point approach show significant deviations at both ends of the concentration range. For the multipoint approach, deviations are more severe at the lower concentration end. Deviation data of the following ion-pairs clearly demonstrate this trend: m/z 138/141 for 13C4-butalbital/butalbital (lower section, Table III (Table VI) .
These deviation trends are expected when considering the effect of cross-contribution on the relative magnitude of errors associated with the apparent ion intensities designated for the analyte and the IS and the nature of multipoint linear regression analysis, in which data at the higher concentration are favorably weighted. Thus, in cases where significant cross-contribution exists, multi-point linear calibration approach produces inferior limits of quantitation and detection. It can, however, extend the calibration range to a higher concentration level.
Linear versus hyperbolic calibration. Hyperbolic models appear to fit the observed calibration data well (last columns of Tables III-VI) . Superior results are obtained in cases where calibration data are derived from ion-pairs with significant cross-contributions (lower sections of Tables III-V and both  sections of Table VI ). Thus, all data derived from the use of 2H 5-analogues as the ISs fit nicely for the entire concentration ranges (25-5000 ng/mL for the butalbital systems and 25--4800 ng/mL for the secobarbital systems). This cannot be achieved by the linear models.
The effectiveness of the hyperbolic model is due to its taking into account the cross-contribution phenomenon as shown (15) . where y is the observed ion-pair intensity ratio; x is moles of the analyte in each standard; X is intensity of the ion designated for the analyte; a is moles of the IS in all standards; A' is intensity of the IS cross-contributed to the ion designated for the analyte; X' is intensity of the analyte cross-contributed to the ion designated for the IS; and A is intensity of the IS for the ion designated for the IS. Constant C1 expresses the cross-contribution of the IS to the intensity of ion designated for the analyte. Constant C2 expresses the cross-contribution of the analyte to the intensity of ion designated for the IS. Constant C3 reflects the moles of the IS used, the relative purities of the analyte and the IS used in preparing the standard solutions, and the relative intensities of the ions designated for the same amount of the analyte and the IS.
Constant C3 equals the concentration of the IS when both the analyte and the IS are 100% pure (chemically and isotopically) with identical mass spectral responses (no isotopic effect). In the absence of cross-contribution between the analyte and the IS, C1 = C2 = 0; thus, the relationship between the analytdIS ion intensity and concentration ratios reduces to a linear function:
where C = 1/C3. It is noted that, at the lower concentration end, results generated by the one-point calibration approach are superior to those derived from the hyperbolic model for the following data sets: m/z 196/200 for 13C4-butalbital/butalbital (upper section, Table III) ; rn/z 196/201 for 2Hs-butalbital/butalbital (upper section, Table IV) ; and m/z 196/200 and for 13C4-secobarbital/secobarbital (upper section, Table V ). In the absence of significant cross-contribution between the analyte and the IS for the adapted ion pairs, a hyperbolic model is not effective to fully account for the data in these data sets.
Detection limit and calibration range
Factors that may affect detection limit and calibration range achievable by a specific analytical protocol include sources associated with processes adapted for sample preparation, chromatography, ionization/fragmentation, and ion detection. Adaptation of an isotopic analogue of the analyte as the IS greatly reduces problems that are related to sample preparation (extraction and chemical derivation), chromatography (retention characteristics), and ionization/fragmentation processes. This approach, however, does not improve problems associated with detector saturation. It also introduces the cross-contribution phenomenon which, as demonstrated, deteriorates the linearity of the apparent ion intensity ratios as measured by SIM protocols that are routinely used in modern clinical/ forensic laboratories.
With the cross-contribution phenomenon accounted for, the hyperbolic calibration model is clearly more effective in fitting calibration data at both the lower and higher analyte concentration ends thus significantly lowering the detection limit and extending the calibration range to a higher level. However, the calibration range cannot be extended indefinitely. At the low concentration end, noise-to-signal ratio and the crosscontribution of the IS to the intensity of the ion designated for the analyte, however insignificant, will incrementally reduce the quality of the observed ion intensity and ratio data. At the high concentration end, detection saturation and the cross-contribution of the analyte to the intensity of the ion designated for the IS, however insignificant, will incrementally decrease the "slope" of the calibration curve. Thus, acceptable sensitivity (increase in analyte/IS ion-pair intensity ratio per unit increase in analyte concentration) of the calibration curve will become the limiting factor.
Conclusions
In the absence of other saturation phenomena (e.g., extraction capacity and detector response), analyte/IS systems that provide ion pairs with insignificant cross-contributions can be most effectively calibrated using the one-point calibration approach (for examples, see data shown in the third columns in the upper sections of Tables III-V) . For systems with significant cross-contribution, the hyperbolic model is equally effective in generating quality calibration data.
